Renalytix Plc (AIM:RENX)
London
· Delayed Price · Currency is GBP · Price in GBX 6.90
-0.10 (-1.43%)
Jul 8, 2025, 4:29 PM GMT+1
Renalytix Market Cap
Renalytix has a market cap or net worth of 23.18 million as of July 8, 2025. Its market cap has increased by 3.58% in one year.
Market Cap
23.18M
Enterprise Value
22.05M
Revenue
2.31M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.90
Market Cap Chart
Since November 6, 2018, Renalytix's market cap has decreased from 64.58M to 23.18M, a decrease of -64.10%. That is a compound annual growth rate of -14.23%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 158.45B |
| GSK plc | 56.46B |
| Haleon | 33.36B |
| Smith & Nephew | 9.70B |
| ConvaTec Group | 5.38B |
| Hikma Pharmaceuticals | 4.37B |
| HUTCHMED (China) | 1.93B |
| Indivior | 1.43B |